+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Bacterial Disease Diagnostics Market 2019-2023 - Product Image

Global Bacterial Disease Diagnostics Market 2019-2023

  • ID: 4790990
  • Report
  • June 2019
  • Region: Global
  • 137 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN Group
  • MORE
Global Bacterial Disease Diagnostics Market: About this market

Bacterial disease diagnostics help in the diagnosis of infectious diseases such as typhoid, malaria, TB, and meningitis, which are caused by bacteria. The bacterial disease diagnostics market analysis considers sales from both instruments and consumables. Our analysis also considers the sales of the bacterial disease diagnostics in North America, Europe, Asia, and ROW. In 2018, the instruments segment had a significant market share. However, the consumables segment is expected to surpass instruments segments in terms of the market share at the end of the forecast period. Factors such as changing consumer demands will play a significant role in the consumables segment to dominate the market. Also, our global bacterial disease diagnostics market report looks at factors such as the integration of digital health in rapid diagnostics for bacterial diseases, a growing number of M&A, and the high prevalence of infectious diseases. However, limitations of electrophoresis systems, lack of accessibility to bacterial diagnostic tests in developing countries, and pricing pressure among vendors may hamper the growth of the bacterial disease diagnostics industry over the forecast period.

Global Bacterial disease diagnostics Market: Overview

Integration of digital health in rapid diagnostics for bacterial diseases

Digital health is increasingly being adopted in remote health monitoring and rapid diagnosis of bacterial diseases. The growing popularity of digital health is attributed to the technological advances in new diagnostic tools that are improving the accuracy of test results. Thus, the integration of digital health in rapid diagnostics will lead to the growth of the global bacterial disease diagnostics market at a CAGR of almost 6% during the forecast period.

High sensitivity and accuracy of chemiluminescence immunoassay

The growing need for detecting small bacterial molecules has resulted in the emergence of chemiluminescence immunoassays (CLIA). CLIA can analyze samples with higher accuracy compared with ELISA in much lesser time. CLIA consumes a smaller number of reagents to carry out assays; hence, the cost involved in this is much lower than its counterparts. Thus, the growing use of chemiluminescence immunoassay will have a positive impact on the global bacterial disease diagnostics market growth during the forecast period.

Competitive Landscape

With the presence of a few significant players, the global bacterial disease diagnostics market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bacterial disease diagnostics manufacturers, that include Abbott, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., and QIAGEN Group.

Also, the bacterial disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN Group
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Instruments - Market size and forecast 2018-2023
  • Consumables - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 10: MARKET TRENDS
  • High sensitivity and accuracy of chemiluminescence immunoassays
  • Growing demand for portable analytical instruments
  • Increasing initiatives for rapid diagnostics of infectious diseases
PART 11: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 12: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN Group
PART 13: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
  • LOE
Exhibit 01: Years in consideration
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market characteristics analysis
Exhibit 06: Market segments
Exhibit 07: Market definition - Inclusions and exclusions checklist
Exhibit 08: Market size 2018
Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 11: Five forces analysis 2018
Exhibit 12: Five forces analysis 2023
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2018
Exhibit 19: Product - Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Instruments - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Instruments - Year-over-year growth 2019-2023 (%)
Exhibit 23: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Customer landscape analysis
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Market impact analysis of M&A
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendor landscape analysis
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Abbott - Vendor overview
Exhibit 50: Abbott - Business segments
Exhibit 51: Abbott - Organizational developments
Exhibit 52: Abbott - Geographic focus
Exhibit 53: Abbott - Segment focus
Exhibit 54: Abbott - Key offerings
Exhibit 55: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 56: Bio-Rad Laboratories Inc. - Business segments
Exhibit 57: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 58: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 59: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 60: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 63: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 67: PerkinElmer Inc. - Vendor overview
Exhibit 68: PerkinElmer Inc. - Business segments
Exhibit 69: PerkinElmer Inc. - Organizational developments
Exhibit 70: PerkinElmer Inc. - Geographic focus
Exhibit 71: PerkinElmer Inc. - Segment focus
Exhibit 72: PerkinElmer Inc. - Key offerings
Exhibit 73: QIAGEN Group - Vendor overview
Exhibit 74: QIAGEN Group - Business segments
Exhibit 75: QIAGEN Group - Organizational developments
Exhibit 76: QIAGEN Group - Geographic focus
Exhibit 77: QIAGEN Group - Segment focus
Exhibit 78: QIAGEN Group - Key offerings
Exhibit 79: Validation techniques employed for market sizing
Exhibit 80: List of abbreviations
Exhibit 81: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN Group
  • MORE
The following companies are recognised as the key players in the global bacterial disease diagnostics market: Abbott, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., and QIAGEN Group.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the high sensitivity and accuracy of chemiluminescence immunoassay.”

According to the report, one of the major drivers for this market is the integration of digital health in rapid diagnostics for bacterial diseases.

Further, the report states that one of the major factors hindering the growth of this market is the limitations of electrophoresis systems.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • QIAGEN Group
Note: Product cover images may vary from those shown
Adroll
adroll